Gateway™ LR Clonase™ Enzyme mix
Product Image
Invitrogen™

Gateway™ LR Clonase™ Enzyme mix

Gateway® LR Clonase® enzyme mix에는 Entry clone (attL site flanking 관심 유전자 함유)과 Destination vector (attR sites 포함) 간의 in자세히 알아보기
Have Questions?
보기 방식 변경buttonViewtableView
카탈로그 번호수량
11791043100 Reactions
1179101920 Reactions
카탈로그 번호 11791043
제품 가격(KRW)
4,068,000
Online offer
Ends: 31-Mar-2026
4,785,000
할인액 717,000 (15%)
Each
카트에 추가하기
수량:
100 Reactions
제품 가격(KRW)
4,068,000
Online offer
Ends: 31-Mar-2026
4,785,000
할인액 717,000 (15%)
Each
카트에 추가하기
Gateway® LR Clonase® enzyme mix에는 Entry clone (attL site flanking 관심 유전자 함유)과 Destination vector (attR sites 포함) 간의 in vitro 재조합에 촉매 작용을 하여 발현 클론을 생성하는 본사 고유의 Int (Integrase), IHF (Integration Host Factor), Xis (Excisionase) enzyme이 들어 있습니다. 본사는 사용 어플리케이션과 원하는 형식에 맞게 여러 가지 LR Clonase enzyme 혼합물을 제공합니다. LR Clonase II Plus enzyme mix는 최신 버전으로 최고의 재조합 효율을 제공하며(표 1), single 및 multiple fragment cloning 모두에 특이적으로 최적화되어 있습니다(표 1). LR Clonase II Plus enzyme mix는 enzyme과 reaction buffer가 최적화된 single mix로 제공되며 single 및 multiple fragment cloning 모두에서 효소 안정성을 높이고 피펫 작업을 줄입니다. LR Clonase II enzyme mix는 single mix 형식으로 구매 가능하며 원래 LR Clonase® enzyme은 각 시험관에 enzyme과 buffer가 따로 들어 있습니다.
For Research Use Only. Not for use in diagnostic procedures.
사양
함께 사용가능한 버퍼Reaction Buffer
제품 유형LR Clonase Enzyme Mix
수량100 Reactions
배송 조건Dry Ice
효소LR Clonase
제품라인Clonase, Gateway
Unit SizeEach
구성 및 보관
All Gateway™ LR Clonase™ enzyme kits include proteinase K solution (2 μg/μl) and a positive control vector. Store LR Clonase™ enzyme at -80°C; LR Clonase™ II or II Plus Enzyme mixtures at -20°C. Guaranteed stable for 6 months when properly stored.

자주 묻는 질문(FAQ)

I performed an LR reaction and got high background after transformation. Can you please offer some troubleshooting tips?

– Check whether the reaction was transformed into an E.coli strain containing the F' episome and the ccdA gene – use an E.coli strain that does not contain the F&339; episome, e.g. OmniMAX 2-T1R, TOP10.
– Deletion (full or partial) of the ccdB gene – propagate in media with 50-100 mg/mL ampicillin and 15-30 µg/mL chloramphenicol.
– Contamination from another resistant strain.
– Check whether proper amount of DNA was used in the reaction.

I performed an LR reaction and got two distinct types of colonies (large and small) after transformation. What could be the possible reasons?

– Plasmid was lost during culture due to large size or toxicity – try incubating at 30 degrees C; use Stbl2 E.coli to stabilize the plasmid.
– Deletions (full or partial) or point mutations in the ccdB gene – obtain a new Destination vector.
– Small colonies may be unreacted entry clone that co-transforms with the Expression clone – reduce the amount of Entry clone to 50 ng per 10 µL reaction; reduce the volume of sample used for transformation to 1 µL; for a Destination vector with ampicillin selection marker, increase the ampicillin concentration to 300 µg/mL.

I performed an LR reaction and got no colonies after transformation, and the recombination positive control was not successful. Can you please offer some suggestions?

– Check the competent cells with pUC19 transformation.
– Increase the amount plated.

I performed an LR reaction and got few or no colonies after transformation, whereas the transformation control gave colonies. Can you please offer some suggestions?

– Increase the incubation time up to 18 hours.
– Make sure to treat reactions with proteinase K before transformation.
– Check whether the correct antibiotic was used for selection.
– Check whether the att site sequences are correct.
– Check whether the correct Clonase enzyme was used and whether it was functional.
– Check whether the recommended amount of DNA was used in the reaction.
– Perform the positive control recombination with pENTR-Gus plasmid.
– If the Entry clone or Destination vector is too large (>10 kb), incubate the LR reaction overnight, linearize the Destination vector or the Entry clone or relax the Destination vector with topoisomerase I.

Can I create a single Entry vector for use with DEST vectors that have N-terminal tags and C-terminal tags?

No, since a stop codon would be necessary for an N-terminal tagged destination vector, whereas the presence of a stop codon would block expression of the C-terminal tag.

인용 및 참조 문헌 (4)

인용 및 참조 문헌
Abstract
High-throughput yeast two-hybrid assays for large-scale protein interaction mapping.
Authors:Walhout AJ, Vidal M,
Journal:Methods
PubMed ID:11403578
'Protein-protein interactions play fundamental roles in many biological processes. Hence, protein interaction mapping is becoming a well-established functional genomics approach to generate functional annotations for predicted proteins that so far have remained uncharacterized. The yeast two-hybrid system is currently one of the most standardized protein interaction mapping techniques. Here, we ... More
Functional identification of Arabidopsis stress regulatory genes using the controlled cDNA overexpression system.
Authors:Papdi C, Abrahám E, Joseph MP, Popescu C, Koncz C, Szabados L,
Journal:Plant Physiol
PubMed ID:18441225
'Responses to environmental stresses in higher plants are controlled by a complex web of abscisic acid (ABA)-dependent and independent signaling pathways. To perform genetic screens for identification of novel Arabidopsis (Arabidopsis thaliana) loci involved in the control of abiotic stress responses, a complementary DNA (cDNA) expression library was created in ... More
Homologous high-throughput expression and purification of highly conserved E coli proteins.
Authors:Ergin A, Büssow K, Sieper J, Thiel A, Duchmann R, Adam T,
Journal:Microb Cell Fact
PubMed ID:17553160
BACKGROUND: Genetic factors and a dysregulated immune response towards commensal bacteria contribute to the pathogenesis of Inflammatory Bowel Disease (IBD). Animal models demonstrated that the normal intestinal flora is crucial for the development of intestinal inflammation. However, due to the complexity of the intestinal flora, it has been difficult to ... More
Human protein factory for converting the transcriptome into an in vitro-expressed proteome,.
Authors:Goshima N, Kawamura Y, Fukumoto A, Miura A, Honma R, Satoh R, Wakamatsu A, Yamamoto J, Kimura K, Nishikawa T, Andoh T, Iida Y, Ishikawa K, Ito E, Kagawa N, Kaminaga C, Kanehori K, Kawakami B, Kenmochi K, Kimura R, Kobayashi M, Kuroita T, Kuwayama H, Maruyama Y, Matsuo K, Minami K, Mitsubori M, Mori M, Morishita R, Murase A, Nishikawa A, Nishikawa S, Okamoto T, Sakagami N, Sakamoto Y, Sasaki Y, Seki T, Sono S, Sugiyama A, Sumiya T, Takayama T, Takayama Y, Takeda H, Togashi T, Yahata K, Yamada H,
Journal:Nat Methods
PubMed ID:19054851
Appropriate resources and expression technology necessary for human proteomics on a whole-proteome scale are being developed. We prepared a foundation for simple and efficient production of human proteins using the versatile Gateway vector system. We generated 33,275 human Gateway entry clones for protein synthesis, developed mRNA expression protocols for them ... More